UBS Group’s ChampionX CHX Stock Holding History

UBS Group’s Portfolio CHX Stock Details CHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-78,800	Closed	-$2.38M	–	9969
2024 Q3	$2.38M	Hold	78,800	–	–	﹤0.01%	3832
2024 Q2	$2.62M	Sell	78,800 -150,000	-66%	-$5.12M	﹤0.01%	3484
2024 Q1	$8.21M	Buy	+228,800	New	+$6.84M	﹤0.01%	2453
2023 Q4	–	Sell	-369,900	Closed	-$13.2M	–	9359
2023 Q3	$13.2M	Sell	369,900 -136,100	-27%	-$4.84M	﹤0.01%	1770
2023 Q2	$15.7M	Buy	506,000 +169,900	+51%	+$4.68M	0.01%	1644
2023 Q1	$9.12M	Buy	+336,100	New	+$10M	﹤0.01%	1957

Other funds holding CHX

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's CHX Position: Q3 2025 in Review

UBS Group sold out of ChampionX (CHX) in Q3 2025, closing a stake of 602,783 shares — an estimated $15M sold.

UBS Group first reported a position in CHX in Q2 2018 and held it in 29 quarters. The position peaked at $52.8M in Q1 2025. 3 funds tracked by Wall St. Rank hold CHX as of Q3 2025.

UBS Group reported no remaining ChampionX position as of Q3 2025 after selling out during the quarter.
UBS Group sold 602,783 ChampionX shares in Q3 2025, an estimated $15M.
UBS Group first reported a position in ChampionX in Q2 2018 and held it in 29 quarters.
UBS Group's ChampionX position peaked at $52.8M in Q1 2025.
3 funds tracked by Wall St. Rank held ChampionX as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.